Sagittarius Life Science Corp (TPEX:3205)
Taiwan
· Delayed Price · Currency is TWD 58.00
+0.20 (0.35%)
Apr 28, 2026, 1:30 PM CST
Sagittarius Life Science Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 346.08 | 467.75 | 440.46 | 529.07 | 587.61 | Upgrade
|
| Revenue Growth (YoY) | -26.01% | 6.20% | -16.75% | -9.96% | 5.27% | Upgrade
|
| Cost of Revenue | 288.37 | 386.64 | 368.98 | 446.5 | 487.07 | Upgrade
|
| Gross Profit | 57.71 | 81.11 | 71.48 | 82.56 | 100.54 | Upgrade
|
| Selling, General & Admin | 94.72 | 124.78 | 114.02 | 142.1 | 158.98 | Upgrade
|
| Research & Development | 21.5 | 17.89 | 21.83 | 22.69 | 31.58 | Upgrade
|
| Operating Expenses | 116.22 | 142.67 | 135.85 | 164.79 | 190.55 | Upgrade
|
| Operating Income | -58.51 | -61.56 | -64.38 | -82.23 | -90.01 | Upgrade
|
| Interest Expense | -0.07 | -0.21 | -0.08 | -0.23 | -0.39 | Upgrade
|
| Interest & Investment Income | 9.77 | 4.93 | 4.59 | 1.48 | 1.26 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -2.98 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.05 | 1.49 | -0.11 | 2.86 | -1.22 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.52 | 2.69 | 3.24 | 3.38 | 2.92 | Upgrade
|
| EBT Excluding Unusual Items | -49.28 | -52.66 | -56.75 | -77.72 | -87.45 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.47 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.13 | 2.98 | -0.08 | 0.01 | -0.01 | Upgrade
|
| Other Unusual Items | - | - | - | 1.21 | - | Upgrade
|
| Pretax Income | -49.88 | -49.68 | -56.82 | -76.5 | -87.46 | Upgrade
|
| Income Tax Expense | - | - | - | -0.01 | - | Upgrade
|
| Earnings From Continuing Operations | -49.88 | -49.68 | -56.82 | -76.49 | -87.46 | Upgrade
|
| Minority Interest in Earnings | 0.31 | 1.15 | 1.79 | 2.29 | 1.04 | Upgrade
|
| Net Income | -49.56 | -48.53 | -55.04 | -74.2 | -86.42 | Upgrade
|
| Net Income to Common | -49.56 | -48.53 | -55.04 | -74.2 | -86.42 | Upgrade
|
| Shares Outstanding (Basic) | 54 | 33 | 33 | 33 | 33 | Upgrade
|
| Shares Outstanding (Diluted) | 54 | 33 | 33 | 33 | 33 | Upgrade
|
| Shares Change (YoY) | 65.82% | - | - | - | -0.22% | Upgrade
|
| EPS (Basic) | -0.92 | -1.49 | -1.69 | -2.28 | -2.66 | Upgrade
|
| EPS (Diluted) | -0.92 | -1.49 | -1.69 | -2.28 | -2.66 | Upgrade
|
| Free Cash Flow | -36.45 | -47.77 | -71.38 | -53.98 | -37.4 | Upgrade
|
| Free Cash Flow Per Share | -0.68 | -1.47 | -2.19 | -1.66 | -1.15 | Upgrade
|
| Gross Margin | 16.68% | 17.34% | 16.23% | 15.60% | 17.11% | Upgrade
|
| Operating Margin | -16.91% | -13.16% | -14.62% | -15.54% | -15.32% | Upgrade
|
| Profit Margin | -14.32% | -10.38% | -12.50% | -14.03% | -14.71% | Upgrade
|
| Free Cash Flow Margin | -10.53% | -10.21% | -16.21% | -10.20% | -6.37% | Upgrade
|
| EBITDA | -53.17 | -53.89 | -57.68 | -74.85 | -81.43 | Upgrade
|
| EBITDA Margin | -15.36% | -11.52% | -13.10% | -14.15% | -13.86% | Upgrade
|
| D&A For EBITDA | 5.34 | 7.67 | 6.7 | 7.38 | 8.59 | Upgrade
|
| EBIT | -58.51 | -61.56 | -64.38 | -82.23 | -90.01 | Upgrade
|
| EBIT Margin | -16.91% | -13.16% | -14.62% | -15.54% | -15.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.